Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Proxima Bio works in Biotechnology Research, out of Melbourne. Ownership is privately held; it publishes at proximabio.com.au. It holds one address on record, all in Australia. The record counts 13 people. One Australian registration (ABN) is a confirmed match. The record links eight similar brands, most of them in Biotechnology Research.
ABN88666622957
| PROXIMA BIO PTY LTD | ABN 88666622957 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Proxima Bio is a venture-backed biotechnology company developing the next generation of medicines, cell surface degraders. Our technology provides new opportunities to target previously undruggable, disease-causing proteins, with powerful potential applications in autoimmune conditions and cancers.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One Victoria entity on the ABR. PROXIMA BIO PTY LTD (ABN 88 666 622 957), high confidence.
The record holds 13 counted staff profiles at January 2026, above the self-reported 2–10 band.
One address on record, Australia only. Primary: Melbourne.
None linked to this brand.
25 profiles list Proxima Bio as a peer — 95th percentile in Biotechnology Research. It lists ten peers of its own. Cell Bauhaus and Cicada Innovations list it back.